-
Something wrong with this record ?
The Influence of Geographical Origin on Poplar Propolis Composition and the Impact of Human Microbiota
M. Miłek, G. Franke, M. Tomczyk, M. Górecki, O. Cwiková, A. Jarošová, M. Dżugan
Status not-indexed Language English Country Switzerland
Document type Journal Article
Grant support
PB/ZCHTZ/2024
Ministry of Science and Higher Education
NLK
Directory of Open Access Journals
from 2009
Free Medical Journals
from 2009
PubMed Central
from 2004
Europe PubMed Central
from 2004
ProQuest Central
from 2004-01-01
Open Access Digital Library
from 2004-01-01
Open Access Digital Library
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2004
PubMed
38931435
DOI
10.3390/ph17060768
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
Ethanol extracts obtained from 13 poplar propolis samples originating from various European countries by traditional maceration were tested for total polyphenols, flavonoid content, and antioxidant activity. Moreover, the content of 18 polyphenolic compounds (from the group of phenolic acids and flavonoids) was determined using the HPLC method. The inhibitory effect of six selected extracts with the highest activity was assessed by well-diffusion method against five strains (Bifidobacterium spp., L. rhamnosus, L. acidophilus, E. coli, and Bacteroides spp.) of intestinal bacteria self-isolated from the faeces of obese probands with the use of selective media. It was found that the antioxidant activity of propolis varied depending on geographical origin and even among samples from the same region, which indicates that some other factors also influence propolis quality. The samples of different geographical origin varied mainly in the share of individual phenolic compounds, and it was not possible to find a characteristic marker of origin, excluding the galangin present in the Polish samples only. Assessing the inhibitory activity of propolis (in the range of 70 mg to 10 μg per mL) indicated that the concentration of 100 μg/mL was found as being safe for tested fecal bacteria (Bifidobacterium spp., L. rhamnosus, L. acidophilus, E. coli, and Bacteroides spp.). As no negative effect of low doses of propolis on the intestinal microflora was found, it can be suggested that its use in recommended doses brings only beneficial effects to the body.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24012554
- 003
- CZ-PrNML
- 005
- 20240726151401.0
- 007
- ta
- 008
- 240723s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ph17060768 $2 doi
- 035 __
- $a (PubMed)38931435
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Miłek, Michał $u Department of Chemistry and Food Toxicology, Institute of Food Technology and Nutrition, University of Rzeszow, Ćwiklińskiej 1a St., 35-601 Rzeszow, Poland $1 https://orcid.org/0000000193122506
- 245 14
- $a The Influence of Geographical Origin on Poplar Propolis Composition and the Impact of Human Microbiota / $c M. Miłek, G. Franke, M. Tomczyk, M. Górecki, O. Cwiková, A. Jarošová, M. Dżugan
- 520 9_
- $a Ethanol extracts obtained from 13 poplar propolis samples originating from various European countries by traditional maceration were tested for total polyphenols, flavonoid content, and antioxidant activity. Moreover, the content of 18 polyphenolic compounds (from the group of phenolic acids and flavonoids) was determined using the HPLC method. The inhibitory effect of six selected extracts with the highest activity was assessed by well-diffusion method against five strains (Bifidobacterium spp., L. rhamnosus, L. acidophilus, E. coli, and Bacteroides spp.) of intestinal bacteria self-isolated from the faeces of obese probands with the use of selective media. It was found that the antioxidant activity of propolis varied depending on geographical origin and even among samples from the same region, which indicates that some other factors also influence propolis quality. The samples of different geographical origin varied mainly in the share of individual phenolic compounds, and it was not possible to find a characteristic marker of origin, excluding the galangin present in the Polish samples only. Assessing the inhibitory activity of propolis (in the range of 70 mg to 10 μg per mL) indicated that the concentration of 100 μg/mL was found as being safe for tested fecal bacteria (Bifidobacterium spp., L. rhamnosus, L. acidophilus, E. coli, and Bacteroides spp.). As no negative effect of low doses of propolis on the intestinal microflora was found, it can be suggested that its use in recommended doses brings only beneficial effects to the body.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Franke, Gabriela $u Department of Food Technology, Faculty of AgriSciences, Mendel University in Brno, Zemědělská 1 St., 613 00 Brno, Czech Republic
- 700 1_
- $a Tomczyk, Monika $u Department of Chemistry and Food Toxicology, Institute of Food Technology and Nutrition, University of Rzeszow, Ćwiklińskiej 1a St., 35-601 Rzeszow, Poland
- 700 1_
- $a Górecki, Miłosz $u PROKIT-Miłosz Górecki, Świętokrzyska 25 St., Kazimierów, 05-074 Halinow, Poland
- 700 1_
- $a Cwiková, Olga $u Department of Food Technology, Faculty of AgriSciences, Mendel University in Brno, Zemědělská 1 St., 613 00 Brno, Czech Republic
- 700 1_
- $a Jarošová, Alžbeta $u Department of Food Technology, Faculty of AgriSciences, Mendel University in Brno, Zemědělská 1 St., 613 00 Brno, Czech Republic
- 700 1_
- $a Dżugan, Małgorzata $u Department of Chemistry and Food Toxicology, Institute of Food Technology and Nutrition, University of Rzeszow, Ćwiklińskiej 1a St., 35-601 Rzeszow, Poland $1 https://orcid.org/0000000316016296
- 773 0_
- $w MED00184066 $t Pharmaceuticals $x 1424-8247 $g Roč. 17, č. 6 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38931435 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240723 $b ABA008
- 991 __
- $a 20240726151354 $b ABA008
- 999 __
- $a ok $b bmc $g 2125405 $s 1224417
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 17 $c 6 $e 20240611 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
- GRA __
- $a PB/ZCHTZ/2024 $p Ministry of Science and Higher Education
- LZP __
- $a Pubmed-20240723